Clinical Trial Update: Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluated safety, pharmacokinetics, and pharmacodynamics of a single dose of CNTO 3649 in healthy adult men and multiple doses in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CNTO 3649

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Healthy, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED